A citation-based method for searching scientific literature

Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
Times Cited: 142



Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey, David E Goldgar, D Gareth R Evans, Georgia Chenevix-Trench, Nazneen Rahman, Mark Robson, Susan M Domchek, William D Foulkes. N Engl J Med 2015
Times Cited: 472




List of shared articles



Times cited

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
3

The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
Yanin Chavarri-Guerra, Carolyn B Hendricks, Sandra Brown, Catherine Marcum, Mary Hander, Zdenka E Segota, Chris Hake, Sharon Sand, Thomas P Slavin, Arti Hurria,[...]. J Am Geriatr Soc 2019
5

Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Jeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, Shu Tao, Charité Ricker, Asaf Maoz, Margalit Rosenblatt, Bita Nehoray, Sharon Sand, Linda Steele,[...]. Cancer 2019
14

The role of BRCA1/2 in hereditary and familial breast and ovarian cancers.
Yousef M Hawsawi, Nouf S Al-Numair, Turki M Sobahy, Areej M Al-Ajmi, Raneem M Al-Harbi, Mohammed A Baghdadi, Atif A Oyouni, Osama M Alamer. Mol Genet Genomic Med 2019
12

An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Carolyn Piccinin, Seema Panchal, Nicholas Watkins, Raymond H Kim. Expert Rev Anticancer Ther 2019
7

Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.
Karen A Cadoo, Diana L Mandelker, Semanti Mukherjee, Carolyn Stewart, Deborah DeLair, Vignesh Ravichandran, Preethi Srinivasan, Daire Hurley, Yelena Kemel, Angela G Arnold,[...]. JCO Precis Oncol 2019
1

Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors.
Michael F Walsh, Rosalba Sacca, Temima Wildman, Kimberly Amoroso, Jennifer Kennedy, Liying Zhang, Ozge Birsoy, Diana Mandelker, Zoe Steinsnyder, Alicia Latham,[...]. JCO Precis Oncol 2019
0

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
Allison H West, Kathleen R Blazer, Jessica Stoll, Matthew Jones, Caroline M Weipert, Sarah M Nielsen, Sonia S Kupfer, Jeffrey N Weitzel, Olufunmilayo I Olopade. Fam Cancer 2018
9

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
63



The future of clinical cancer genomics.
Kenneth Offit. Semin Oncol 2016
13


Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R Blazer, Jeffrey N Weitzel. Front Oncol 2015
64